Sunshine Biopharma Inc. (SBFM) Net margin 2019–2025
Sunshine Biopharma Inc. (SBFM) net profit margin by fiscal year — reported net income divided by reported revenue.
-16.5%FY2025 · since FY2019: -7860.9% → -16.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.5% | -1.7 pp |
| FY2024 | -14.7% | +4.0 pp |
| FY2023 | -18.7% | +596.7 pp |
| FY2022 | -615.4% | +4829.0 pp |
| FY2021 | -5444.4% | -1545.7 pp |
| FY2020 | -3898.7% | +3962.1 pp |
| FY2019 | -7860.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFM financial trends
SBFM RevenueSBFM Net incomeSBFM Gross profitSBFM Gross marginSBFM Operating incomeSBFM Operating marginSBFM Operating cash flowSBFM Free cash flowSBFM Capital expendituresSBFM Return on equitySBFM Stock buybacksSBFM Dividends paidSBFM Total assetsSBFM Total liabilitiesSBFM Shareholders’ equitySBFM overview →